[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Nuclear Receptor ROR-Gamma Market Report 2018

March 2018 | 105 pages | ID: UC02F20415AQEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Nuclear Receptor ROR-Gamma market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Nuclear Receptor ROR-Gamma in these regions, from 2013 to 2025 (forecast).
United States Nuclear Receptor ROR-Gamma market competition by top manufacturers/players, with Nuclear Receptor ROR-Gamma sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • 4SC AG
  • Advinus Therapeutics Ltd.
  • Arrien Pharmaceuticals, LLC
  • Aurigene Discovery Technologies Limited
  • Biogen, Inc.
  • Brickell Biotech, Inc.
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Genentech, Inc.
  • Genfit SA
  • GlaxoSmithKline Plc
  • Hanmi Pharmaceuticals, Co. Ltd.
  • Karo Bio AB
  • Lead Pharma Holding B.V.
  • Nuevolution AB
  • Phenex Pharmaceuticals AG
  • Reata Pharmaceuticals, Inc.
  • Teijin Pharma Limited
  • Visionary Pharmaceuticals, Inc.
  • Vitae Pharmaceuticals, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • VPR-66
  • INV-17
  • GSK-2981278
  • BBI-6000
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Nuclear Receptor ROR-Gamma Market Report 2018

1 NUCLEAR RECEPTOR ROR-GAMMA OVERVIEW

1.1 Product Overview and Scope of Nuclear Receptor ROR-Gamma
1.2 Classification of Nuclear Receptor ROR-Gamma by Product Category
  1.2.1 United States Nuclear Receptor ROR-Gamma Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Nuclear Receptor ROR-Gamma Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 VPR-66
  1.2.4 INV-17
  1.2.5 GSK-2981278
  1.2.6 BBI-6000
  1.2.7 Others
1.3 United States Nuclear Receptor ROR-Gamma Market by Application/End Users
  1.3.1 United States Nuclear Receptor ROR-Gamma Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Nuclear Receptor ROR-Gamma Market by Region
  1.4.1 United States Nuclear Receptor ROR-Gamma Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
  1.4.3 Southwest Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
  1.4.5 New England Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
  1.4.6 The South Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
  1.4.7 The Midwest Nuclear Receptor ROR-Gamma Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Nuclear Receptor ROR-Gamma (2013-2025)
  1.5.1 United States Nuclear Receptor ROR-Gamma Sales and Growth Rate (2013-2025)
  1.5.2 United States Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2013-2025)

2 UNITED STATES NUCLEAR RECEPTOR ROR-GAMMA MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Nuclear Receptor ROR-Gamma Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Nuclear Receptor ROR-Gamma Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Nuclear Receptor ROR-Gamma Average Price by Players/Suppliers (2013-2018)
2.4 United States Nuclear Receptor ROR-Gamma Market Competitive Situation and Trends
  2.4.1 United States Nuclear Receptor ROR-Gamma Market Concentration Rate
  2.4.2 United States Nuclear Receptor ROR-Gamma Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nuclear Receptor ROR-Gamma Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NUCLEAR RECEPTOR ROR-GAMMA SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Nuclear Receptor ROR-Gamma Sales and Market Share by Region (2013-2018)
3.2 United States Nuclear Receptor ROR-Gamma Revenue and Market Share by Region (2013-2018)
3.3 United States Nuclear Receptor ROR-Gamma Price by Region (2013-2018)

4 UNITED STATES NUCLEAR RECEPTOR ROR-GAMMA SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Nuclear Receptor ROR-Gamma Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Nuclear Receptor ROR-Gamma Revenue and Market Share by Type (2013-2018)
4.3 United States Nuclear Receptor ROR-Gamma Price by Type (2013-2018)
4.4 United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Type (2013-2018)

5 UNITED STATES NUCLEAR RECEPTOR ROR-GAMMA SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Nuclear Receptor ROR-Gamma Sales and Market Share by Application (2013-2018)
5.2 United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES NUCLEAR RECEPTOR ROR-GAMMA PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 4SC AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 4SC AG Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Advinus Therapeutics Ltd.
  6.2.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Arrien Pharmaceuticals, LLC
  6.3.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Aurigene Discovery Technologies Limited
  6.4.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biogen, Inc.
  6.5.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Brickell Biotech, Inc.
  6.6.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb Company
  6.7.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Celgene Corporation
  6.8.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Genentech, Inc.
  6.9.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Genfit SA
  6.10.2 Nuclear Receptor ROR-Gamma Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Genfit SA Nuclear Receptor ROR-Gamma Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 GlaxoSmithKline Plc
6.12 Hanmi Pharmaceuticals, Co. Ltd.
6.13 Karo Bio AB
6.14 Lead Pharma Holding B.V.
6.15 Nuevolution AB
6.16 Phenex Pharmaceuticals AG
6.17 Reata Pharmaceuticals, Inc.
6.18 Teijin Pharma Limited
6.19 Visionary Pharmaceuticals, Inc.
6.20 Vitae Pharmaceuticals, Inc.

7 NUCLEAR RECEPTOR ROR-GAMMA MANUFACTURING COST ANALYSIS

7.1 Nuclear Receptor ROR-Gamma Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Receptor ROR-Gamma

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nuclear Receptor ROR-Gamma Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Receptor ROR-Gamma Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NUCLEAR RECEPTOR ROR-GAMMA MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Nuclear Receptor ROR-Gamma Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Nuclear Receptor ROR-Gamma Sales Volume Forecast by Type (2018-2025)
11.3 United States Nuclear Receptor ROR-Gamma Sales Volume Forecast by Application (2018-2025)
11.4 United States Nuclear Receptor ROR-Gamma Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Receptor ROR-Gamma
Figure United States Nuclear Receptor ROR-Gamma Market Size (K Pcs) by Type (2013-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume Market Share by Type (Product Category) in 2017
Figure VPR-66 Product Picture
Figure INV-17 Product Picture
Figure GSK-2981278 Product Picture
Figure BBI-6000 Product Picture
Figure Others Product Picture
Figure United States Nuclear Receptor ROR-Gamma Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Nuclear Receptor ROR-Gamma by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Nuclear Receptor ROR-Gamma Market Size (Million USD) by Region (2013-2025)
Figure The West Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Nuclear Receptor ROR-Gamma Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Nuclear Receptor ROR-Gamma Sales Share by Players/Suppliers
Figure 2017 United States Nuclear Receptor ROR-Gamma Sales Share by Players/Suppliers
Figure United States Nuclear Receptor ROR-Gamma Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Nuclear Receptor ROR-Gamma Revenue Share by Players/Suppliers
Figure 2017 United States Nuclear Receptor ROR-Gamma Revenue Share by Players/Suppliers
Table United States Market Nuclear Receptor ROR-Gamma Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Nuclear Receptor ROR-Gamma Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Nuclear Receptor ROR-Gamma Market Share of Top 3 Players/Suppliers
Figure United States Nuclear Receptor ROR-Gamma Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nuclear Receptor ROR-Gamma Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nuclear Receptor ROR-Gamma Product Category
Table United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Region (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales Share by Region (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Share by Region (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Market Share by Region in 2017
Table United States Nuclear Receptor ROR-Gamma Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Revenue Share by Region (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Revenue Market Share by Region (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Revenue Market Share by Region in 2017
Table United States Nuclear Receptor ROR-Gamma Price (USD/Pcs) by Region (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Type (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales Share by Type (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Share by Type (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Market Share by Type in 2017
Table United States Nuclear Receptor ROR-Gamma Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nuclear Receptor ROR-Gamma by Type (2013-2018)
Figure Revenue Market Share of Nuclear Receptor ROR-Gamma by Type in 2017
Table United States Nuclear Receptor ROR-Gamma Price (USD/Pcs) by Types (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Type (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales (K Pcs) by Application (2013-2018)
Table United States Nuclear Receptor ROR-Gamma Sales Market Share by Application (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Market Share by Application (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Market Share by Application in 2017
Table United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Application (2013-2018)
Figure United States Nuclear Receptor ROR-Gamma Sales Growth Rate by Application (2013-2018)
Table 4SC AG Basic Information List
Table 4SC AG Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure 4SC AG Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure 4SC AG Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure 4SC AG Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Advinus Therapeutics Ltd. Basic Information List
Table Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Arrien Pharmaceuticals, LLC Basic Information List
Table Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Aurigene Discovery Technologies Limited Basic Information List
Table Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Biogen, Inc. Basic Information List
Table Biogen, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biogen, Inc. Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Biogen, Inc. Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Brickell Biotech, Inc. Basic Information List
Table Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Celgene Corporation Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Celgene Corporation Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Celgene Corporation Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Genentech, Inc. Basic Information List
Table Genentech, Inc. Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genentech, Inc. Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Genentech, Inc. Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table Genfit SA Basic Information List
Table Genfit SA Nuclear Receptor ROR-Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genfit SA Nuclear Receptor ROR-Gamma Sales Growth Rate (2013-2018)
Figure Genfit SA Nuclear Receptor ROR-Gamma Sales Market Share in United States (2013-2018)
Figure Genfit SA Nuclear Receptor ROR-Gamma Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table Hanmi Pharmaceuticals, Co. Ltd. Basic Information List
Table Karo Bio AB Basic Information List
Table Lead Pharma Holding B.V. Basic Information List
Table Nuevolution AB Basic Information List
Table Phenex Pharmaceuticals AG Basic Information List
Table Reata Pharmaceuticals, Inc. Basic Information List
Table Teijin Pharma Limited Basic Information List
Table Visionary Pharmaceuticals, Inc. Basic Information List
Table Vitae Pharmaceuticals, Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Receptor ROR-Gamma
Figure Manufacturing Process Analysis of Nuclear Receptor ROR-Gamma
Figure Nuclear Receptor ROR-Gamma Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Receptor ROR-Gamma Major Players/Suppliers in 2017
Table Major Buyers of Nuclear Receptor ROR-Gamma
Table Distributors/Traders List
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Nuclear Receptor ROR-Gamma Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Nuclear Receptor ROR-Gamma Sales Volume Share Forecast by Region (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume Share Forecast by Region (2018-2025)
Figure United States Nuclear Receptor ROR-Gamma Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories